Urapidil impurity compound, preparation method and application thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- 燃点(南京)生物医药科技有限公司
- Publication Date
- 2020-12-18
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the technical field of pharmaceutical impurity preparation, in particular to an urapidil impurity compound, a preparation method and an application thereof. Background technique
[0002] Urapidil (Urapidil), structural formula II is a highly selective α-receptor blocker with both peripheral and central effects. The peripheral vasodilation effect is mainly to block the post-synaptic α1 receptor, so that the peripheral resistance is significantly reduced, and the central effect is to reduce blood pressure by activating the 5-hydroxytryptamine-1A receptor and reducing the sympathetic feedback regulation of the medullary cardiovascular center. Urapidil preparations have two dosage forms: oral and injection. The raw material used in the oral dosage form is Urapidil, and the raw drug used in the injection is Urapidil Hydrochloride (Urapidil Hydrochloride), with a structural formula such as formula III. Urapidil sustained-release tab...